{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:47:11Z","timestamp":1792608431300,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.rmed.2020.106190","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T04:21:38Z","timestamp":1605241298000},"page":"106190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Use of mucolytics in COPD: A Delphi consensus study"],"prefix":"10.1016","volume":"175","author":[{"given":"Alberto","family":"Papi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Avdeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.A.","family":"Calverley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos R.","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Jesenak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Kobl\u00ed\u017eek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Petkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Tarraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tzanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruxandra","family":"Ulmeanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Uzaslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yochai","family":"Adir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2020.106190_bib1","series-title":"Global Strategy for Diagnosis, Management and Prevention of COPD","year":"2020"},{"issue":"3","key":"10.1016\/j.rmed.2020.106190_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02265-2016","article-title":"J.A. Krishnan. Prevention of COPD exacerbations: a European respiratory society\/American thoracic society guideline","volume":"50","author":"Wedzicha","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.rmed.2020.106190_bib3","doi-asserted-by":"crossref","first-page":"847\u2012852","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"issue":"13","key":"10.1016\/j.rmed.2020.106190_bib4","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJMoa1105482","article-title":"Changes in forced expiratory volume in 1 second over time in COPD","volume":"365","author":"Vestbo","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"5 Pt 1","key":"10.1016\/j.rmed.2020.106190_bib5","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2020.106190_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1513\/AnnalsATS.201208-043OC","article-title":"Predictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease","volume":"10","author":"Singanayagam","year":"2013","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.rmed.2020.106190_bib7","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.2147\/COPD.S139470","article-title":"Impact and prevention of severe exacerbations of COPD: a review of the evidence","volume":"12","author":"Halpin","year":"2017","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"issue":"3","key":"10.1016\/j.rmed.2020.106190_bib8","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/ijcp.12522","article-title":"COPD: early diagnosis and treatment to slow disease progression","volume":"69","author":"Welte","year":"2015","journal-title":"Int. J. Clin. Pract."},{"issue":"4","key":"10.1016\/j.rmed.2020.106190_bib9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1378\/chest.08-2062","article-title":"Initiatives Bronchopneumopathie Chronique Obstructive (BPCO) Scientific Committee. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects","volume":"135","author":"Burgel","year":"2009","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.rmed.2020.106190_bib10","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.rmed.2011.02.003","article-title":"Cough and sputum production as risk factors for poor outcomes in patients with COPD","volume":"105","author":"Miravitlles","year":"2011","journal-title":"Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2020.106190_bib11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.chest.2019.06.023","article-title":"Do cough and sputum production predict COPD exacerbations?: the evidence is growing","volume":"156","author":"Martin","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2020.106190_bib12","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.2147\/COPD.S221852","article-title":"Effect of Erdosteine on COPD exacerbations in COPD patients with moderate airflow limitation","volume":"14","author":"Calverley","year":"2019","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2020.106190_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.rmed.2018.12.014","article-title":"Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: a post-hoc analysis of the PANTHEON study","volume":"147","author":"Papi","year":"2019","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2020.106190_bib14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1183\/13993003.01170-2015","article-title":"A review of national guidelines for management of COPD in Europe","volume":"47","author":"Miravitlles","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2020.106190_bib15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2147\/COPD.S4257","article-title":"Geographic differences in clinical characteristics and management of COPD: the EPOCA study","volume":"3","author":"Miravitlles","year":"2008","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.rmed.2020.106190_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.rmed.2015.12.004","article-title":"Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study","volume":"111","author":"Barrecheguren","year":"2016","journal-title":"Respir. Med."},{"issue":"7","key":"10.1016\/j.rmed.2020.106190_bib17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tips.2019.04.015","article-title":"Thiol-based drugs in pulmonary medicine: much more than mucolytics","volume":"40","author":"Cazzola","year":"2019","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.rmed.2020.106190_bib18","series-title":"The Delphi Technique: Techniques and Applications","author":"Linstone","year":"1975"},{"issue":"4","key":"10.1016\/j.rmed.2020.106190_bib19","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","article-title":"Research guidelines for the Delphi survey technique","volume":"32","author":"Hasson","year":"2000","journal-title":"J. Adv. Nurs."},{"issue":"9","key":"10.1016\/j.rmed.2020.106190_bib20","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s10096-018-3264-0","article-title":"Attitudes of physicians from 10 European countries on adherence and how treatment modalities in ABSSSI affect adherence: results from a Delphi survey","volume":"37","author":"Stargardt","year":"2018","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"issue":"5","key":"10.1016\/j.rmed.2020.106190_bib21","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1080\/15412555.2017.1347918","article-title":"Impact of mucolytic agents on COPD exacerbations: a pair-wise and network meta-analysis","volume":"14","author":"Cazzola","year":"2017","journal-title":"COPD"},{"issue":"5","key":"10.1016\/j.rmed.2020.106190_bib22","first-page":"331","article-title":"Comparison between penetration of amoxicillin combined with carbocysteine and amoxicillin alone in pathological bronchial scretions and pulmonary tissue","volume":"5","author":"Braga","year":"1985","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"10.1016\/j.rmed.2020.106190_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/thx.43.8.585","article-title":"Influenc eof erdosteine, a mucolytic agent, on amoxycillin penetration into sputum in patients with an infective exacerbation of chronic bronchitis","volume":"43","author":"Ricevuti","year":"1988","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.rmed.2020.106190_bib26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12931-019-1078-y","article-title":"Efficacy and safety profile of mucolytic\/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine","volume":"20","author":"Rogliani","year":"2019","journal-title":"Respir. Res."},{"key":"10.1016\/j.rmed.2020.106190_bib27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.rmed.2017.06.007","article-title":"Adherence to COPD treatment: myth and reality","volume":"129","author":"Rogliani","year":"2017","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2020.106190_bib28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.alit.2016.10.008","article-title":"Kyushu Asthma Seminar Investigators. Poor pharmacological adherence to inhaled medicines compared with oral medicines in Japanese patients with asthma and chronic obstructive pulmonary disease","volume":"66","author":"Imamura","year":"2017","journal-title":"Allergol. Int."},{"issue":"9470","key":"10.1016\/j.rmed.2020.106190_bib29","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","article-title":"Effects of N-acetylcysteine on outcomes in chronic obstructive disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomized placebo-controlled trial","volume":"365","author":"Decramer","year":"2005","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.rmed.2020.106190_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S2213-2600(13)70286-8","article-title":"PANTHEON study group. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial","volume":"2","author":"Zheng","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"9629","key":"10.1016\/j.rmed.2020.106190_bib31","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(08)60869-7","article-title":"Effect of carbocysteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomized placebo-controlled study","volume":"371","author":"Zheng","year":"2008","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.rmed.2020.106190_bib32","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00711-2017","article-title":"Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study","volume":"50","author":"Dal Negro","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2020.106190_bib33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MCP.0000000000000145","article-title":"The chronic bronchitis phenotype in COPD: features and implications","volume":"21","author":"Kim","year":"2015","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"2","key":"10.1016\/j.rmed.2020.106190_bib34","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02470-2016","article-title":"Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease","volume":"50","author":"Lahousse","year":"2017","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2020.106190_bib35","article-title":"Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease","volume":"5","author":"Poole","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"10","key":"10.1016\/j.rmed.2020.106190_bib36","first-page":"1","article-title":"The Delphi technique: making sense of consensus","volume":"12","author":"Hsu","year":"2007","journal-title":"Practical Assess. Res. Eval."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120303309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611120303309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:07:24Z","timestamp":1760616444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611120303309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":34,"alternative-id":["S0954611120303309"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2020.106190","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of mucolytics in COPD: A Delphi consensus study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2020.106190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106190"}}